Literature DB >> 23430355

Impairment of executive cognitive control in type 2 diabetes, and its effects on health-related behavior and use of health services.

Dinh Tran1, Judith Baxter, Richard F Hamman, Jim Grigsby.   

Abstract

We evaluated whether, among persons with type 2 diabetes: (1) impaired executive cognitive functioning (ECF) is more common than among people without diabetes; (2) ECF is associated with the capacity to engage in instrumental health-related behaviors; and (3) worse ECF is associated with increased health services utilization. A population-based sample of 1,063 older people was interviewed regarding medical history and health services utilization; participants were administered the Mini Mental State Exam and the Behavioral Dyscontrol Scale, a measure of ECF. Participants with diabetes performed more poorly on cognitive measures than those without diabetes. Among those with diabetes, lower ECF was associated with more outpatient care and with ever having been in a nursing home. Impaired behavioral self-regulation may affect the capacity to engage in behaviors that could improve clinical status, resulting in greater health services use. The findings suggest the possibility of a positive feedback loop, with ECF deficits adversely affecting adherence, in turn leading to greater cognitive impairment-an issue for future research.

Entities:  

Mesh:

Year:  2013        PMID: 23430355      PMCID: PMC3718846          DOI: 10.1007/s10865-013-9499-4

Source DB:  PubMed          Journal:  J Behav Med        ISSN: 0160-7715


  34 in total

Review 1.  Executive frontal functions.

Authors:  J M Fuster
Journal:  Exp Brain Res       Date:  2000-07       Impact factor: 1.972

2.  Methods and prevalence of ADL limitations in Hispanic and non-Hispanic white subjects in rural Colorado: the San Luis Valley Health and Aging Study.

Authors:  R F Hamman; C L Mulgrew; J Baxter; S M Shetterly; C Swenson; N E Morgenstern
Journal:  Ann Epidemiol       Date:  1999-05       Impact factor: 3.797

3.  Mini-Cog and Mini-Mental State Examination: agreement in a cross-sectional study with an elderly sample.

Authors:  Diogo Costa; Milton Severo; Sílvia Fraga; Henrique Barros
Journal:  Dement Geriatr Cogn Disord       Date:  2012-04-12       Impact factor: 2.959

4.  Medication adherence behaviors in older adults: effects of external cognitive supports.

Authors:  D C Park; R W Morrell; D Frieske; D Kincaid
Journal:  Psychol Aging       Date:  1992-06

5.  Executive cognitive abilities and functional status among community-dwelling older persons in the San Luis Valley Health and Aging Study.

Authors:  J Grigsby; K Kaye; J Baxter; S M Shetterly; R F Hamman
Journal:  J Am Geriatr Soc       Date:  1998-05       Impact factor: 5.562

6.  Correlates of medication nonadherence among Latinos with type 2 diabetes.

Authors:  Humberto Parada; Lucy A Horton; Andrea Cherrington; Leticia Ibarra; Guadalupe X Ayala
Journal:  Diabetes Educ       Date:  2012-04-30       Impact factor: 2.140

7.  Neuropsychological functioning in older people with type 2 diabetes: the effect of controlling for confounding factors.

Authors:  K G Asimakopoulou; S E Hampson; N J Morrish
Journal:  Diabet Med       Date:  2002-04       Impact factor: 4.359

8.  Structured assessment of independent living skills: preliminary report of a performance measure of functional abilities in dementia.

Authors:  R K Mahurin; B H DeBettignies; F J Pirozzolo
Journal:  J Gerontol       Date:  1991-03

Review 9.  Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Authors:  Silvio E Inzucchi; Richard M Bergenstal; John B Buse; Michaela Diamant; Ele Ferrannini; Michael Nauck; Anne L Peters; Apostolos Tsapas; Richard Wender; David R Matthews
Journal:  Diabetes Care       Date:  2012-04-19       Impact factor: 19.112

10.  Poor cognitive function and risk of severe hypoglycemia in type 2 diabetes: post hoc epidemiologic analysis of the ACCORD trial.

Authors:  Zubin Punthakee; Michael E Miller; Lenore J Launer; Jeff D Williamson; Ronald M Lazar; Tali Cukierman-Yaffee; Elizabeth R Seaquist; Faramarz Ismail-Beigi; Mark D Sullivan; Laura C Lovato; Richard M Bergenstal; Hertzel C Gerstein
Journal:  Diabetes Care       Date:  2012-02-28       Impact factor: 19.112

View more
  5 in total

Review 1.  Harnessing centred identity transformation to reduce executive function burden for maintenance of health behaviour change: the Maintain IT model.

Authors:  Ann E Caldwell; Kevin S Masters; John C Peters; Angela D Bryan; Jim Grigsby; Stephanie A Hooker; Holly R Wyatt; James O Hill
Journal:  Health Psychol Rev       Date:  2018-02-19

2.  Diabetes, Obesity, and the Brain: New Developments in Biobehavioral Medicine.

Authors:  Susan A Everson-Rose; John P Ryan
Journal:  Psychosom Med       Date:  2015 Jul-Aug       Impact factor: 4.312

3.  Type 2 Diabetes Interacts With Alzheimer Disease Risk Factors to Predict Functional Decline.

Authors:  Kelsey R Thomas; Katherine J Bangen; Alexandra J Weigand; Emily C Edmonds; Erin Sundermann; Christina G Wong; Joel Eppig; Madeleine L Werhane; Lisa Delano-Wood; Mark W Bondi
Journal:  Alzheimer Dis Assoc Disord       Date:  2020 Jan-Mar       Impact factor: 2.703

4.  Executive functioning and diabetes: The role of anxious arousal and inflammation.

Authors:  Kyle W Murdock; Angie S LeRoy; Tamara E Lacourt; Danny C Duke; Cobi J Heijnen; Christopher P Fagundes
Journal:  Psychoneuroendocrinology       Date:  2016-05-18       Impact factor: 4.905

5.  Duration of type 2 diabetes and very low density lipoprotein levels are associated with cognitive dysfunction in metabolic syndrome.

Authors:  Divya Yogi-Morren; Rachel Galioto; Sarah Elizabeth Strandjord; L Kennedy; Pooja Manroa; John P Kirwan; Sangeeta Kashyap; John Gunstad
Journal:  Cardiovasc Psychiatry Neurol       Date:  2014-06-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.